Brind.

Jay Bradner is a doctor at Amgen.

4 reports, 2 independent Updated Nov 1
Gone quiet
Reports
4
Developments
3
Repetition
25%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Jay Bradner is a doctor at Amgen.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Jay Bradner reinforced confidence in Amgen's growth, and Gordon took a new executive role.1 source
  2. Jay Bradner has been identified as a doctor at Amgen since August 12, 2025.1 source
  3. Jay Bradner's role at Amgen is detailed alongside Zai Lab's commercialization rights in Macau and China.

Keep exploring

The entities involved

  • Jay Bradner

    research scientist at Harvard and Dana Farber

    Nothing else this week.

  • Amgen

    American multinational biopharmaceutical company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • themarketsdaily.com
  • Insider MonkeyAmgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN)
  • Unknown outlet
  • Unknown outlet